佰仁医疗 (688198.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(佰仁医疗)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 89,747,018.38102,752,415.5064,891,611.9774,426,625.9079,804,664.3374,929,847.5166,005,581.98
 营业收入(元) 89,747,018.38102,752,415.5064,891,611.9774,426,625.9079,804,664.3374,929,847.5166,005,581.98
二、营业总成本(元) 65,843,496.3774,999,356.8756,358,692.6148,533,569.6958,522,965.0251,341,451.5952,611,993.70
 营业成本(元) 8,110,269.7710,920,098.597,536,034.948,697,582.837,650,768.867,526,058.557,486,443.90
 研发费用(元) 23,719,835.9121,960,050.6217,404,587.4310,548,271.3716,672,860.5913,230,987.1814,695,524.66
 营业税金及附加(元) 550,358.14613,981.38432,983.12400,385.97410,288.19437,343.30455,264.18
 销售费用(元) 26,306,908.7532,562,630.1224,451,761.9323,302,044.1426,513,040.8025,815,220.7424,413,965.25
 管理费用(元) 7,134,902.439,167,498.326,706,497.145,931,003.617,350,406.374,523,210.215,921,094.67
 财务费用(元) 21,221.37-224,902.16-173,171.95-345,718.23-74,399.79-191,368.39-360,298.96
  其中:利息费用(元) 113,249.27111,594.7516,077.4417,448.6420,602.0020,937.1620,901.84
  其中:利息收入(元) 164,433.78249,782.22208,001.63376,466.79119,055.49217,260.13397,699.52
 信用减值损失(元) -775,172.97-239,491.76427,744.48-747,233.79-31,128.28-829,248.60-111,299.78
三、其他经营收益
 加:公允价值变动收益(元) 1,273,444.12781,757.701,198,197.60-1,893,856.33721,194.11455,171.881,606,407.34
 加:投资收益(元) 2,183,754.172,944,997.502,706,949.5514,885,240.932,001,093.283,021,543.811,507,099.39
 资产处置收益(元) ------12,715.91
 其他收益(元) 242,080.282,357,795.291,236,684.98412,244.502,018,364.005,682.96228,817.59
四、营业利润(元) 26,827,627.6133,647,906.8014,102,495.9738,549,451.5225,991,222.4226,241,545.9716,637,328.73
 加:营业外收入(元) -1,943.3631,320.0055.50358.94-17,600.00
 减:营业外支出(元) 1,078.24605,549.75663.43782,000.00100,088.4528,547.11390,807.50
五、利润总额(元) 26,826,549.3733,044,300.4114,133,152.5437,767,507.0225,891,492.9126,212,998.8616,264,121.23
 减:所得税费用(元) 1,993,602.27836,755.322,707,616.342,791,239.963,542,408.412,701,861.272,693,506.57
六、净利润(元) 24,832,947.1032,207,545.0911,425,536.2034,976,267.0622,349,084.5023,511,137.5913,570,614.66
(一)按经营持续性分类
  持续经营净利润(元) 24,832,947.1032,207,545.0911,425,536.2034,976,267.0622,349,084.5023,511,137.5913,570,614.66
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 26,126,038.5132,521,854.8311,698,274.5735,285,243.0922,554,571.7123,691,771.3213,606,919.59
  少数股东损益(元) -1,293,091.41-314,309.74-272,738.37-308,976.03-205,487.21-180,633.73-36,304.93
 扣除非经常性损益后的净利润(元) 24,155,679.5428,868,136.689,016,201.1828,892,492.2118,503,973.2320,688,717.7910,901,795.62
七、每股收益
 一、基本每股收益(元) 0.190.240.090.260.160.140.14
 二、稀释每股收益(元) 0.190.230.090.260.170.130.14
八、其他综合收益(元) -393,551.032,169,975.6735,493.45-76,511.90-65,648.05-19,095.25173,909.15
 归属于母公司股东的其他综合收益(元) -393,551.032,169,975.6735,493.45-76,511.90-65,648.05-19,095.25173,909.15
九、综合收益总额(元) 24,439,396.0734,377,520.7611,461,029.6534,899,755.1622,283,436.4523,492,042.3413,744,523.81
 归属于母公司所有者的综合收益总额(元) 25,732,487.4834,691,830.5011,733,768.0235,208,731.1922,488,923.6623,672,676.0713,780,828.74
 归属于少数股东的综合收益总额(元) -1,293,091.41-314,309.74-272,738.37-308,976.03-205,487.21-180,633.73-36,304.93
公告日期 2023-10-312023-08-302023-04-202023-04-202022-10-262022-08-292022-04-22
审计意见(境内) 标准无保留意见

前瞻产业研究院